Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors
- Status
- COMPLETED
- Phase
- NA
VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2